N-[(3S,4R)-1-[(2R)-6-amino-2-(cyclohexylamino)hexanoyl]-3-(thiophen-2-ylmethylcarbamoyl)piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(4-ethylphenyl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[(3S,4R)-1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(3-methyl-1H-indol-5-yl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[(3S,4R)-1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(2-methyl-4-pyridinyl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide

C132H191N23O12S5 — CID 161431118

IUPACN-[(3S,4R)-1-[(2R)-6-amino-2-(cyclohexylamino)hexanoyl]-3-(thiophen-2-ylmethylcarbamoyl)piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(4-ethylphenyl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[(3S,4R)-1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(3-methyl-1H-indol-5-yl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[(3S,4R)-1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(2-methyl-4-pyridinyl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide
SMILESCCc1ccc(CNC(=O)C2CN(C(=O)[C@@H](CC3CCCCC3)NC3CCCCC3)CCC2NC(=O)c2ncc(C)s2)cc1.Cc1cc(CNC(=O)[C@H]2CN(C(=O)[C@@H](CC3CCCCC3)NC3CCCCC3)CC[C@H]2NC(=O)c2ncc(C)s2)ccn1.Cc1cnc(C(=O)N[C@@H]2CCN(C(=O)[C@@H](CC3CCCCC3)NC3CCCCC3)C[C@@H]2C(=O)NCc2ccc3[nH]cc(C)c3c2)s1.Cc1cnc(C(=O)N[C@@H]2CCN(C(=O)[C@@H](CCCCN)NC3CCCCC3)C[C@@H]2C(=O)NCc2cccs2)s1
InChIInChI=1S/C36H50N6O3S.C35H51N5O3S.C33H48N6O3S.C28H42N6O3S2/c1-23-19-37-30-14-13-26(17-28(23)30)21-38-33(43)29-22-42(16-15-31(29)41-34(44)35-39-20-24(2)46-35)36(45)32(18-25-9-5-3-6-10-25)40-27-11-7-4-8-12-27;1-3-25-14-16-27(17-15-25)22-36-32(41)29-23-40(19-18-30(29)39-33(42)34-37-21-24(2)44-34)35(43)31(20-26-10-6-4-7-11-26)38-28-12-8-5-9-13-28;1-22-17-25(13-15-34-22)20-35-30(40)27-21-39(16-14-28(27)38-31(41)32-36-19-23(2)43-32)33(42)29(18-24-9-5-3-6-10-24)37-26-11-7-4-8-12-26;1-19-16-31-27(39-19)26(36)33-23-12-14-34(18-22(23)25(35)30-17-21-10-7-15-38-21)28(37)24(11-5-6-13-29)32-20-8-3-2-4-9-20/h13-14,17,19-20,25,27,29,31-32,37,40H,3-12,15-16,18,21-22H2,1-2H3,(H,38,43)(H,41,44);14-17,21,26,28-31,38H,3-13,18-20,22-23H2,1-2H3,(H,36,41)(H,39,42);13,15,17,19,24,26-29,37H,3-12,14,16,18,20-21H2,1-2H3,(H,35,40)(H,38,41);7,10,15-16,20,22-24,32H,2-6,8-9,11-14,17-18,29H2,1H3,(H,30,35)(H,33,36)/t29-,31+,32+;29?,30?,31-;27-,28+,29+;22-,23+,24+/m0100/s1
InChIKeyVYAHEKJSZQYDPV-XCNJELKDSA-N
MW2452.46 g/mol
LogP19.18
Rot. Bonds43

About N-[(3S,4R)-1-[(2R)-6-amino-2-(cyclohexylamino)hexanoyl]-3-(thiophen-2-ylmethylcarbamoyl)piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(4-ethylphenyl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[(3S,4R)-1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(3-methyl-1H-indol-5-yl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[(3S,4R)-1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(2-methyl-4-pyridinyl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide

N-[(3S,4R)-1-[(2R)-6-amino-2-(cyclohexylamino)hexanoyl]-3-(thiophen-2-ylmethylcarbamoyl)piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(4-ethylphenyl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[(3S,4R)-1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(3-methyl-1H-indol-5-yl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[(3S,4R)-1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(2-methyl-4-pyridinyl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide (PubChem CID 161431118) has the molecular formula C132H191N23O12S5 and a molecular weight of 2452.46 g/mol. Its IUPAC name is N-[(3S,4R)-1-[(2R)-6-amino-2-(cyclohexylamino)hexanoyl]-3-(thiophen-2-ylmethylcarbamoyl)piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(4-ethylphenyl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[(3S,4R)-1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(3-methyl-1H-indol-5-yl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[(3S,4R)-1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(2-methyl-4-pyridinyl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide.

Molecular Properties

Compound NameN-[(3S,4R)-1-[(2R)-6-amino-2-(cyclohexylamino)hexanoyl]-3-(thiophen-2-ylmethylcarbamoyl)piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(4-ethylphenyl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[(3S,4R)-1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(3-methyl-1H-indol-5-yl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[(3S,4R)-1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(2-methyl-4-pyridinyl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide
PubChem CID161431118
Molecular FormulaC132H191N23O12S5
Molecular Weight2452.46 g/mol
Exact Mass2450.36
IUPAC NameN-[(3S,4R)-1-[(2R)-6-amino-2-(cyclohexylamino)hexanoyl]-3-(thiophen-2-ylmethylcarbamoyl)piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(4-ethylphenyl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[(3S,4R)-1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(3-methyl-1H-indol-5-yl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[(3S,4R)-1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(2-methyl-4-pyridinyl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide
SMILESCCc1ccc(CNC(=O)C2CN(C(=O)[C@@H](CC3CCCCC3)NC3CCCCC3)CCC2NC(=O)c2ncc(C)s2)cc1.Cc1cc(CNC(=O)[C@H]2CN(C(=O)[C@@H](CC3CCCCC3)NC3CCCCC3)CC[C@H]2NC(=O)c2ncc(C)s2)ccn1.Cc1cnc(C(=O)N[C@@H]2CCN(C(=O)[C@@H](CC3CCCCC3)NC3CCCCC3)C[C@@H]2C(=O)NCc2ccc3[nH]cc(C)c3c2)s1.Cc1cnc(C(=O)N[C@@H]2CCN(C(=O)[C@@H](CCCCN)NC3CCCCC3)C[C@@H]2C(=O)NCc2cccs2)s1
InChIInChI=1S/C36H50N6O3S.C35H51N5O3S.C33H48N6O3S.C28H42N6O3S2/c1-23-19-37-30-14-13-26(17-28(23)30)21-38-33(43)29-22-42(16-15-31(29)41-34(44)35-39-20-24(2)46-35)36(45)32(18-25-9-5-3-6-10-25)40-27-11-7-4-8-12-27;1-3-25-14-16-27(17-15-25)22-36-32(41)29-23-40(19-18-30(29)39-33(42)34-37-21-24(2)44-34)35(43)31(20-26-10-6-4-7-11-26)38-28-12-8-5-9-13-28;1-22-17-25(13-15-34-22)20-35-30(40)27-21-39(16-14-28(27)38-31(41)32-36-19-23(2)43-32)33(42)29(18-24-9-5-3-6-10-24)37-26-11-7-4-8-12-26;1-19-16-31-27(39-19)26(36)33-23-12-14-34(18-22(23)25(35)30-17-21-10-7-15-38-21)28(37)24(11-5-6-13-29)32-20-8-3-2-4-9-20/h13-14,17,19-20,25,27,29,31-32,37,40H,3-12,15-16,18,21-22H2,1-2H3,(H,38,43)(H,41,44);14-17,21,26,28-31,38H,3-13,18-20,22-23H2,1-2H3,(H,36,41)(H,39,42);13,15,17,19,24,26-29,37H,3-12,14,16,18,20-21H2,1-2H3,(H,35,40)(H,38,41);7,10,15-16,20,22-24,32H,2-6,8-9,11-14,17-18,29H2,1H3,(H,30,35)(H,33,36)/t29-,31+,32+;29?,30?,31-;27-,28+,29+;22-,23+,24+/m0100/s1
InChIKeyVYAHEKJSZQYDPV-XCNJELKDSA-N
XLogP19.18
TPSA468.42 Ų
H-Bond Donors14
H-Bond Acceptors27
Rotatable Bonds43
Heavy Atoms172
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002452.46
LogP ≤ 519.18
H-Bond Donors ≤ 514
H-Bond Acceptors ≤ 1027

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[(3S,4R)-1-[(2R)-6-amino-2-(cyclohexylamino)hexanoyl]-3-(thiophen-2-ylmethylcarbamoyl)piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(4-ethylphenyl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[(3S,4R)-1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(3-methyl-1H-indol-5-yl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[(3S,4R)-1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(2-methyl-4-pyridinyl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[(3S,4R)-1-[(2R)-6-amino-2-(cyclohexylamino)hexanoyl]-3-(thiophen-2-ylmethylcarbamoyl)piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(4-ethylphenyl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[(3S,4R)-1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(3-methyl-1H-indol-5-yl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[(3S,4R)-1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(2-methyl-4-pyridinyl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide?
The IUPAC name of N-[(3S,4R)-1-[(2R)-6-amino-2-(cyclohexylamino)hexanoyl]-3-(thiophen-2-ylmethylcarbamoyl)piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(4-ethylphenyl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[(3S,4R)-1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(3-methyl-1H-indol-5-yl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[(3S,4R)-1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(2-methyl-4-pyridinyl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide (CID 161431118) is N-[(3S,4R)-1-[(2R)-6-amino-2-(cyclohexylamino)hexanoyl]-3-(thiophen-2-ylmethylcarbamoyl)piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(4-ethylphenyl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[(3S,4R)-1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(3-methyl-1H-indol-5-yl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[(3S,4R)-1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(2-methyl-4-pyridinyl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide.
What is the SMILES notation for N-[(3S,4R)-1-[(2R)-6-amino-2-(cyclohexylamino)hexanoyl]-3-(thiophen-2-ylmethylcarbamoyl)piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(4-ethylphenyl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[(3S,4R)-1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(3-methyl-1H-indol-5-yl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[(3S,4R)-1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(2-methyl-4-pyridinyl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide?
The canonical SMILES for N-[(3S,4R)-1-[(2R)-6-amino-2-(cyclohexylamino)hexanoyl]-3-(thiophen-2-ylmethylcarbamoyl)piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(4-ethylphenyl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[(3S,4R)-1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(3-methyl-1H-indol-5-yl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[(3S,4R)-1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(2-methyl-4-pyridinyl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide is CCc1ccc(CNC(=O)C2CN(C(=O)[C@@H](CC3CCCCC3)NC3CCCCC3)CCC2NC(=O)c2ncc(C)s2)cc1.Cc1cc(CNC(=O)[C@H]2CN(C(=O)[C@@H](CC3CCCCC3)NC3CCCCC3)CC[C@H]2NC(=O)c2ncc(C)s2)ccn1.Cc1cnc(C(=O)N[C@@H]2CCN(C(=O)[C@@H](CC3CCCCC3)NC3CCCCC3)C[C@@H]2C(=O)NCc2ccc3[nH]cc(C)c3c2)s1.Cc1cnc(C(=O)N[C@@H]2CCN(C(=O)[C@@H](CCCCN)NC3CCCCC3)C[C@@H]2C(=O)NCc2cccs2)s1.
What is the InChIKey of N-[(3S,4R)-1-[(2R)-6-amino-2-(cyclohexylamino)hexanoyl]-3-(thiophen-2-ylmethylcarbamoyl)piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(4-ethylphenyl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[(3S,4R)-1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(3-methyl-1H-indol-5-yl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[(3S,4R)-1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(2-methyl-4-pyridinyl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide?
The InChIKey is VYAHEKJSZQYDPV-XCNJELKDSA-N. The full InChI is InChI=1S/C36H50N6O3S.C35H51N5O3S.C33H48N6O3S.C28H42N6O3S2/c1-23-19-37-30-14-13-26(17-28(23)30)21-38-33(43)29-22-42(16-15-31(29)41-34(44)35-39-20-24(2)46-35)36(45)32(18-25-9-5-3-6-10-25)40-27-11-7-4-8-12-27;1-3-25-14-16-27(17-15-25)22-36-32(41)29-23-40(19-18-30(29)39-33(42)34-37-21-24(2)44-34)35(43)31(20-26-10-6-4-7-11-26)38-28-12-8-5-9-13-28;1-22-17-25(13-15-34-22)20-35-30(40)27-21-39(16-14-28(27)38-31(41)32-36-19-23(2)43-32)33(42)29(18-24-9-5-3-6-10-24)37-26-11-7-4-8-12-26;1-19-16-31-27(39-19)26(36)33-23-12-14-34(18-22(23)25(35)30-17-21-10-7-15-38-21)28(37)24(11-5-6-13-29)32-20-8-3-2-4-9-20/h13-14,17,19-20,25,27,29,31-32,37,40H,3-12,15-16,18,21-22H2,1-2H3,(H,38,43)(H,41,44);14-17,21,26,28-31,38H,3-13,18-20,22-23H2,1-2H3,(H,36,41)(H,39,42);13,15,17,19,24,26-29,37H,3-12,14,16,18,20-21H2,1-2H3,(H,35,40)(H,38,41);7,10,15-16,20,22-24,32H,2-6,8-9,11-14,17-18,29H2,1H3,(H,30,35)(H,33,36)/t29-,31+,32+;29?,30?,31-;27-,28+,29+;22-,23+,24+/m0100/s1.
What are the key properties of N-[(3S,4R)-1-[(2R)-6-amino-2-(cyclohexylamino)hexanoyl]-3-(thiophen-2-ylmethylcarbamoyl)piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(4-ethylphenyl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[(3S,4R)-1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(3-methyl-1H-indol-5-yl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[(3S,4R)-1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(2-methyl-4-pyridinyl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide?
N-[(3S,4R)-1-[(2R)-6-amino-2-(cyclohexylamino)hexanoyl]-3-(thiophen-2-ylmethylcarbamoyl)piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(4-ethylphenyl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[(3S,4R)-1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(3-methyl-1H-indol-5-yl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[(3S,4R)-1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(2-methyl-4-pyridinyl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide has a molecular weight of 2452.46 g/mol, XLogP of 19.18, 43 rotatable bonds, 14 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(3S,4R)-1-[(2R)-6-amino-2-(cyclohexylamino)hexanoyl]-3-(thiophen-2-ylmethylcarbamoyl)piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(4-ethylphenyl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[(3S,4R)-1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(3-methyl-1H-indol-5-yl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide;N-[(3S,4R)-1-[(2R)-3-cyclohexyl-2-(cyclohexylamino)propanoyl]-3-[(2-methyl-4-pyridinyl)methylcarbamoyl]piperidin-4-yl]-5-methyl-1,3-thiazole-2-carboxamide is sourced from PubChem (CID 161431118), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).